# Tumor Microenvironment Analysis (LungPredict Project)

**Affiliation:** INSERM U1037 â€“ Centre de Recherches en CancÃ©rologie de Toulouse (CRCT)  
**Period:** 2020â€“2023  
**Project:** LungPredict â€“ Transcriptomic Characterization of Lung Tumor Microenvironments  
**Note:** Analytical contribution not credited in final publication  

---

## ðŸ§­ Context
The LungPredict project explored the heterogeneity of lung tumors by characterizing their **immune composition** and **regulatory activities** from bulk transcriptomic data.  
The goal was to uncover molecular features reflecting immune infiltration, stromal components, and potential therapeutic targets.

---

## ðŸŽ¯ Objectives
- Deconvolute bulk RNA-seq profiles to estimate immune and stromal cell proportions.  
- Infer transcriptional activities of immune-related regulators and signaling pathways.  
- Correlate cellular composition with clinical and pathological parameters.  

---

## ðŸ§ª Methods
- **Data sources:** Bulk RNA-seq datasets from lung adenocarcinoma and squamous carcinoma cohorts.  
- **Preprocessing:** Alignment, quantification, normalization, and QC of raw reads.  
- **Deconvolution:** Estimation of immune cell fractions using tools such as CIBERSORT, EPIC, and TIMER.  
- **Functional inference:** Pathway enrichment (GSEA) and regulatory activity prediction (DoRothEA, PROGENy).  
- **Integration:** Comparative analysis of immune subtypes and transcriptional programs across samples.  

---

## ðŸ’¡ Contributions
- Processed bulk RNA-seq datasets and performed immune cell deconvolution analyses.  
- Estimated transcription factor and pathway activities from normalized expression matrices.  
- Supported result integration and visualization for internal reporting and consortium communication.  
- Helped interpret immune landscape variability in relation to tumor histology.  

---

## ðŸ“˜ Key Skills
Transcriptomic deconvolution Â· RNA-seq analysis Â· Pathway inference Â· Data integration Â· Oncology bioinformatics  

---

## ðŸ”— Reference
Internal contribution to the **LungPredict** research program, CRCT (Toulouse).  
Results integrated into subsequent studies of immune landscape in lung cancer (uncredited).
